Clinical Response With Pembrolizumab for Cutaneous Squamous Cell Carcinoma

被引:2
|
作者
Corbett, Mel [1 ,4 ]
Tohani, Shivangy [1 ]
Ramli, Ruzaimi [1 ]
O'Duffy, Fergal [1 ,2 ,3 ]
机构
[1] Univ Coll Dublin, Head & Neck Oncol Grp, Dublin, Ireland
[2] St Vincents Univ Hosp, Dept Head & Neck Surg, Dublin, Ireland
[3] Mater Misericordiae Univ Hosp, Dept Head & Neck Surg, Dublin, Ireland
[4] St Vincents Univ Hosp, Elm Pk, Dublin, Ireland
关键词
D O I
10.1001/jamaoto.2024.0544
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
This case report describes an 89-year-old patient with prior cutaneous squamous cell carcinoma who presented with a new isolated metastasis and was subsequently treated with pembrolizumab, which produced a complete clinical response.
引用
收藏
页码:524 / 525
页数:2
相关论文
共 50 条
  • [1] Efficacy of pembrolizumab in patients with cutaneous squamous cell carcinoma
    Ferrarotto, R.
    Glisson, B.
    Blumenschein, G.
    Hong, D.
    Piha-Paul, S.
    Ahnert, J. Rodon
    Pant, S.
    Tsimberidou, A.
    Janku, F.
    Alshawa, A.
    Jain, D.
    Rejon, M.
    Hess, K.
    Colen, R.
    Lu, C.
    Stephen, B.
    Tapia, C.
    Mendoza, T.
    Meric-Bernstam, F.
    Naing, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E75 - E75
  • [2] Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab
    Venkatesh, Samantha
    Al-Haseni, Ali
    Sahni, Debjani
    BMJ CASE REPORTS, 2019, 12 (08)
  • [3] Advanced Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab
    Villegas-Romero, I.
    Jimenez-Gallo, D.
    Gutierrez-Bayard, L.
    Linares-Barrios, M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (07): : 672 - 675
  • [4] Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinoma
    Blaise, Manon
    Poissonnet, Gilles
    Cardot-Leccia, Nathalie
    Sudaka, Anne
    Velin, Marine
    Chassang, Madleen
    Razzouk-Cadet, Micheline
    Picard-Gauci, Alexandra
    Passeron, Thierry
    Montaudie, Henri
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (11) : E1318 - E1320
  • [5] Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma
    Degache, E.
    Crochet, J.
    Simon, N.
    Tardieu, M.
    Trabelsi, S.
    Moncourier, M.
    Templier, I.
    Foroni, L.
    Lemoigne, A.
    Pinel, N.
    Gil, H.
    Bouillet, L.
    Leccia, M. T.
    Charles, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : E257 - E258
  • [6] Development of cutaneous squamous cell carcinoma during pembrolizumab therapy
    Mizutani, Kento
    Nakanishi, Takehisa
    Ikejiri, Makoto
    Yuasa, Hiroto
    Matsushima, Yoshiaki
    Kondo, Makoto
    Nakai, Yasuo
    Habe, Koji
    Nakatani, Kaname
    Yamanaka, Keiichi
    JOURNAL OF DERMATOLOGY, 2021, 48 (01): : E7 - E8
  • [7] Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma
    Giri, Anshu
    Bauman, Jessica R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) : 1029 - 1038
  • [8] Report Significant response to Pembrolizumab for metastatic cutaneous squamous cell carcinoma in patient with Netherton syndrome
    Tos, Salem M.
    Alqam, Bilal Nabeel
    Giacaman, Narmeen
    Ibdah, Mohammad G.
    Gabajah, Mahmoud M. M.
    Altell, Abdallah
    ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [9] Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report
    Takahashi-Watanabe, Manami
    Fujimura, Taku
    Amagai, Ryo
    Ohuchi, Kentaro
    Yamazaki, Emi
    Tamabuchi, Erika
    Kuroki, Shigeru
    Kambayashi, Yumi
    Hashimoto, Akira
    Asano, Yoshihide
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1500 - 1503
  • [10] Massive Periocular Squamous Cell Carcinoma With Response to Pembrolizumab (Keytruda)
    Conger, Jordan R.
    Grob, Seanna R.
    Tao, Jeremiah
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 35 (05): : E127 - E127